BSO Communications (General Information & Circulars)

Febuxostat: updated advice for the treatment of patients with a history of major cardiovascular disease

Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines

Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment

Care in the Sun Action cancer letter  5th June 2023

Prescription submission reminder  5th June 2023

Living Well update – Surveys reinstated letter (22/05/23)

SUMMARY - ESSURE CONTRACEPTIVE DEVICES  17th May 2023

Care In The Sun Start Letter  15th May 2023

Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality  02.05.23

Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions 02.05.23

END OF THE 2022/23 FLU SEASON AND RELATED ISSUES  2nd May 2023

Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years  28.04.2023

BREASTFEEDING WELCOME HERE SCHEME REMINDER  18th April 2023

Prescription submission reminder  6th April 2023

Living Well survey pause and delay update letter30th March 2023

COVID-19 THERAPEUTIC ALERT: PUBLICATION OF THE NICE MULTIPLE TECHNOLOGY APPRAISAL (MTA) – TREATMENT RECOMMENDATIONS FOR COVID -19  30.03.2023

Living Well – Look after your eyes start letter   21st March 2023

CMO Letter - STRATEGY FOR MPOX (FORMERLY KNOWN AS MONKEYPOX) CONTROL plus UK Strategy 21st March 2023

CHANGES TO THE HPV VACCINATION SCHEDULE - REDUCTION TO ONE DOSE  20th March 2023

JCVI ADVICE ON 2023 COVID-19 SPRING BOOSTER PROGRAMME AND SIGNIFICANT CHANGES TO THE PRIMARY COURSE OFFER  20th March 2023

PHOLCODINE: DRUG SAFETY UPDATE- PHOLCODINE-CONTAINING COUGH AND COLD MEDICINES: WITHDRAWAL FROM UK MARKET AS A PRECAUTIONARY MEASURE  14th March 2023

PREPARING FOR A SPRING COVID-19 VACCINATION BOOSTER PROGRAMME 01.03.2023

Prescription submission reminder  2nd March 2023

Part III appliance out of pocket pilot- January 2023  14th February 2023

JCVI ADVICE ON 2023 COVID-19 VACCINATION PROGRAMME  2nd February 2023

Prescription Submission Reminder  31st January 2023

PRESCRIBING OF UNLICENSED OR OFF-LABEL MEDICINES FOR THE MANAGEMENT OF COVID-19 OR POST-COVID-19 SYNDROME  30th January 2023

SUPPLY OF LICENSED AND UNLICENSED EPIDURAL BAGS – NATIONAL PATIENT SAFETY ALERT 25.01.23

Letter - Pharmacy Contract Roll Forward 2022 - 23

CHANGES TO THE HPV VACCINATION SCHEDULE  16th January 2023

COMMUNITY PHARMACY SERVICE: LIVING WELL CAMPAIGNS  16th January 2023

Serious Shortage Protocols: Submission Information for Contractors NI : Reminder  3rd Jan 2023

How to Obtain Urgent Medicines Over the Christmas Bank Holiday Long Weekend 22nd Dec 2022

VALPROATE: DRUG SAFETY UPDATE- REMINDER OF THE CURRENT PREGNANCY PREVENTION PROGRAMME REQUIREMENTS; INFORMATION ON NEW SAFETY MEASURES  14th December 2022

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)-RISKS ASSOCIATED WITH TRAVEL TO QATAR FIFA WORLD CUP  9th December 2022

CONFIRMED INFLUENZA IN NI - NICE GUIDANCE ON USE OF ANTIVIRALS NOW APP LIES 9th Dec 2022

GUIDANCE ON PLACE OF BIRTH: IMMEDIATE ACTION REQUIRED  22nd November 2022

Living Well – Home accident prevention start letter  17th November 2022

Letter from Canice Ward to registered pharmacies re private prescribing  14th November 2022

Winter letter from Prof Sir Michael McBride and Attachment  14th November 2022

Grant Funding Allocation - DM+D Clinical System Amendment   9th November 2022

LETTER TO ALL FRONTLINE HSC WORKERS - ENCOURAGING EVERYONE TO BE VACCINATED FOR INFLUENZA AND COVID-19 THIS AUTUMN / WINTER  9th November 2022

UPDATED COVID-19 TESTING GUIDANCE TO SUPPORT CLINICAL PATHWAYS  9th November 2022

Letter from Minister Swann  27th October 2022

PUBLIC HEALTH MESSAGE TO ALL HEALTH AND SOCIAL CARE PROVIDERS REGARDING EBOLA VIRUS OUTBREAK IN UGANDA (SUDAN EBOLAVIRUS)   updated 26th October 2022

RETIRED COST EFFECTIVE CHOICES: PRESCRIBE GENERICALLY  24th October 2022

Liothyronine prescribing: choice of formulation  20th Octber 2022

Promoting Safer Sleeping For Infants Guidance  13th October 2022

Revised 2022 Promoting Safe Sleeping for Infants Guidance  13th October 2022

Changes to the Distribution of Paper Copies of BNF and BNFC Letter

Changes to the Distribution of Paper BNF - Updated

Living Well – Protect yourself this winter start letter  6th October 2022

Monkeypox Vaccination  29th September 2022

PHA - Learning From Falls  September 2022

WORLD PATIENT SAFETY DAY - 17 SEPTEMBER 2022 POSTPONED TO 28 SEPTEMBER 2022 23.09.22

TECOVIRIMAT AS A TREATMENT FOR PATIENTS HOSPITALISED DUE TO MONKEYPOX VIRAL INFECTION 21.09.22

Update GLP1 agonists – Liraglutide & Semaglutide for managing overweight and obesity 15.09.22

WORLD PATIENT SAFETY DAY 17 SEPTEMBER 2022 EVENTS POSTPONED  14th Sept 2022

Bank Holiday - Monday 19th September 2022

EUROPEAN MEDICINES AGENCY (EMA) APPROVAL OF COMIRNATY AND SPIKEVAX BIVALENT ORIGINAL / OMICRON BA.1 COVID-19 VACCINES  8th September 2022

SHINGLES VACCINATION PROGRAMME - ELIGIBILITY CRITERIA FOR 2022/23  1st Sept 2022

SEASONAL INFLUENZA VACCINATION PROGRAMME 2022/23  1st September 2022

SUPPLY AND PACKAGING OF QIC AND LAIV VACCINE DURING 2022/23 INFLUENZA SEASON    PIL 1 and PIL 2   1st September 2022

COVID-19 BOOSTER VACCINATION PROGRAMME FOR AUTUMN 2022  31st August 2022

LIMITED SUPPLIES OF VARIVAX® and VARILRIX® INJECTION AVAILABLE UNTIL MID OCT 2022

Serious Shortage Protocols: Submission Information for Contractors  19th Aug 2022

WORLD PATIENT SAFETY DAY - 17 SEPTEMBER 2022

Living Well - Spot Cancer Early  12th August 2022

Specialist Stop Smoking Services - Expired Elite Claims  11th August 2022

Removal of Derma UK products from NI Drug Tariff  5th August 2022

NATIONAL PATIENT SAFETY ALERT – SHORTAGE OF ALTEPLASE AND TENECTEPLASE INJECTIONS 5th August 2022

COMMUNITY PHARMACY SERVICES 2022/23

Monkeypox Vaccination  27th July 2022

Pharmacy Opening Hours

TOPIRAMATE (TOPAMAX): START OF SAFETY REVIEW TRIGGERED BY A STUDY REPORTING AN INCREASED RISK OF NEURODEVELOPMENTAL DISABILITIES IN CHILDREN WITH PRENATAL EXPOSURE  25th July 2022

PALIVIZUMAB PASSIVE IMMUNISATION AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN AT-RISK PRE-TERM INFANTS – START OF PROGRAMME  14th July 2022

Living Well - 2022/23 Schedule Update  13th July 2022

Reminder - Campaign 1 - "Know Check Ask"  15th June 2022

Monkeypox Vaccination  15th June 2022

MPS 2904 - Hypromellose 0.3% eye drops 10ml  15th June 2022

MONKEYPOX BECOMES A NOTIFIABLE DISEASE IN NORTHERN IRELAND

RESPONSIBILITY FOR PRESCRIBING BETWEEN PRIMARY, SECONDARY AND TERTIARY CARE SERVICES FOR THE SUPPLY OF MEDICINES AND OTHER PHARMACEUTICAL PRODUCTS Letter

RESPONSIBILITY FOR PRESCRIBING BETWEEN PRIMARY, SECONDARY AND TERTIARY CARE SERVICES FOR THE SUPPLY OF MEDICINES AND OTHER PHARMACEUTICAL PRODUCTS

 

Living Well - Know Check Ask extension letter  18th May 2022

IMMEDIATE ACTIONS IN RESPONSE TO CASES OF MONKEYPOX VIRUS IN UK WITH NO KNOWN TRAVEL HISTORY  17.05.2022

NEW STATUTORY RULES

THE GENERAL MEDICAL SERVICES CONTRACTS (AMENDMENT) REGULATIONS (NORTHERN IRELAND) 2022

THE PHARMACEUTICAL SERVICES (AMENDMENT) REGULATIONS (NORTHERN IRELAND) 2022

Panoramic Study Update  28th April 2022

END OF THE 2021/22 FLU SEASON AND RELATED ISSUES  20th April 2022

TRANSFER OF THE HSCB CONTROLLED DRUGS ACCOUNTABLE OFFICER ROLE TO THE DOH 31st March 2022

Product Recall Information notice - Abbott recalls two infant formula powders (Update) 23.02.2022

Product Recall Information notice - Abbott recalls two infant formula powders because of the possible presence of Salmonella 22nd February 2022

CHANGES TO THE VACCINE OF THE HUMAN PAPILLOMA VIRUS (HPV) VACCINATION PROGRAMME   18th February 2022

PALIVIZUMAB PASSIVE IMMUNISATION AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN AT-RISK PRE-TERM INFANTS  28th January 2022

Contractors Providing Opioid Substitution Treatment (OST):Prescribing and Dispensing of Methadone tablets  20th December

UPDATE OF GUIDANCE ON CLEARANCE AND MANAGEMENT OF HEALTHCARE WORKERS LIVING WITH A BLOODBORNE VIRUS (BBV)  16th December 2021

VACCINATION ISSUES –COVID-19 VACCINATION PROGRAMME  8th December 2021

JCVI ADVICE ON THE VACCINE RESPONSE TO THE OMICRON VARIANT  6th December 2021

Reminder - Continued Use of Urgent Pandemic Packs in Nursing Homes 28.10.21

Medicines Management Newsletter Supplement - IDDSI  26th Oct 2021

Medicines Management Newsletter - October 2021

COVID - CPVS  Eligible Patient for Booster   21st October 2021

 MPS 2810 - Endorsement of Specials  18th October 2021

Dysphagia Regional Guidance Letter 12th October 2021

Learning Matters Special Edition October 21  8th Oct 2021

Medicines Management Newsletter - September 2021   8th Oct 2021

ADDENDUM - SEASONAL INFLUENZA VACCINATION PROGRAMME 2021/22 1st Oct 2021

COVID-19 BOOSTER VACCINE PROGRAMME FOR WINTER 2021/22  24th Sept 2021

Update Letter - Campaign Extension   23rd September 2021

Grant Funding Allocation - Letter  17th September 2021

Grant Funding Allocation - Additional Staff Costs Sept 21  17th September 2021

Seasonal Influenza Vaccination Programme 2021/22   16th September 2021

Pharmacy Collect NI - Lateral Flow Device Update  7th Sept 2011

Supply Issues Update - September 2021

Urgent Safety Communication - Gentamicin Intrathecal 5mg/ml Solution 7th Sept 2021

Living Well Additional Cancer Resource  7th September 2021

SHINGLES VACCINATION PROGRAMME – ELIGIBILITY CRITERIA FOR 2021/22 AND INTRODUCTION OF SHINGRIX® FOR IMMUNO COMPROMISED 27th August 2021

LABELLING OF FLUENZ TETRA® VACCINE DURING 2021/22 INFLUENZA SEASON  27th Aug 2021

POTENT SYNTHETIC OPIOIDS IMPLICATED IN INCREASE IN DRUG OVERDOSES  24th Aug 2021

Patient Safety Group - repeat of the patient safety and culture survey   12th August 2021

Pause on vaccination of low priority groups and change to the ordering process for pneumococcal polysaccharide vaccine (pneumovax®23), vaccine for the national immunisation programme  9th August 2021

Alert to Community Pharmacies - Missing Prescription Pad  4th August 2021

Learning From Adverse Incidents - Prescribing of Strong Opioids in Syringe Drivers  3rd August 2021

Better Days Pain Support Programmes - September to November 2021Flyer  3rd Aug 2021

Change of Dose Intervals Between Pfizer-Biontech & Moderna COVID-19 Vaccines  30th July 2021

POLYETHYLENE GLYCOL (PEG) LAXATIVES AND STARCH-BASED THICKENERS: POTENTIAL INTERACTIVE EFFECT WHEN MIXED, LEADING TO AN INCREASED RISK OF ASPIRATION  30.07.2021

COVID Recognition Payment  29th July 2021

Risk to Patient Safety : Parallel Imports of Thickeners & Thickened ONS  27th July 2021

Revised RQIA/GAIN Hyperkalaemia Guidline  27th July 2021

Medicines Management Newsletter - July 2021

CPO to Community Pharmacy Contractors - FTY Grants  26th July 2021

Fully Vaccinated HSC Staff Told to Self-Isolate - Attendence 23rd July 2021

Use of EMA authorised medicines & Joint letter   23rd July 2021

PPE and Heat: Risk of Heat Stress  23rd July 2021

Freestyle Libre Pathway  20th July 2021

Community Pharmacy Service : Living Well Campaigns  19th July 2021

MUR Service Evaluation Letter  19th July 2021

MUR Service Evaluation Bulletin  19th July 2021 

PALIVIZUMAB PASSIVE IMMUNISATION AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN AT-RISK PRE-TERM INFANTS 19th July 2021

Palivizumab RPS  19th July 2021

Pharmaceutical Committee Nomination Form  19th July 2021

Patient Safety Alert - Philips Ventilator - CPAP BiPAP Devices  28th June 2021

MPS 2791 - Prescription Submissions  28th June 2021

Hepatitis C Becomes a Notifiable Disease in Northern Ireland  17th June 2021

Consultation on Duty of Candour  21st May 2021

Letter from Canice Ward - Sales of Ephedrine and Pseudoephedrine May 2021  19.05.21

Supply Route for Insulin Safety Needles and Safety Lancets  19th May 2021

Change to the Supply Route of Pneumococcal Polysaccharide Vaccine 18th May 2021

Community Pharmacy Service : Living Well Campaigns  17th May 2021

Medicines Optimisation Regional Efficiency (MORE) Programme Letter 7th May 2021

HSC Policy Statement on Implementation of MORE  7th May 2021

Living Well 2021-22 Schedule Letter  7th May 2021

MPS 2779 - Melatonin 2mg, 3mg and 5mg capsules (Colonis Pharma Ltd)  6th May 2021

Combination anti-platelet therapy for patients who have a coronary stent  28th April 2021

Appendix A - DAPT Patient Letter  28th April 2021

Appendix B - DAPT Professional Staff Information Leaflet  28th April 2021

End of 2020/21 Flu Season and Related Issues  23rd April 2021

Living Well Campaign 2 and Campaign 3 Reminder  22nd April 2021

Resumption of Probity Processes  22nd April 2021

Potential Diversion of Oromucosal Buprenorphine (Espranor)  22nd April 2021

National Patient Safety Alert - Corticosteroid Medication  29th March 2021

Oral Emergency Contraception  26th March 2021

Patient Safety Alert - BD I.V. and Gravity Feed Infusion Sets  16th March 2021

Patient Safety Alert - BD  16th March 2021

Patient Safety Alert - MHRA  16th March 2021

Controlled Drug Declaration and Self-Assessment 2021  16th March 2021

Changeover to Freestyle Libre 2 Sensors - Letter / Comparrison Table / Template / PIL 19th February 2021

Stock Requisitions : Learning From Recent Review  19th February 2021

HSC Staff Recognition Payment - 15th February

Controlled Drugs : Private Prescriptions (PCD1s) and Private Stock Requisitions (CDRF1s) - Reminder  10th February 2021

Prescription Submission Reminder   3rd February 2021

Learning from Serious Adverse Incident (SAI) : Action Required when a Patient Receiving Oral Substitution Treatment (OST) Misses Doses or Circumstances Change (Jan 2021)

Safety of Antiepileptic Drugs in Pregnancy - Updated Advice  28th January 2021

Prescribing of Vitamin D as a Preventative Measure Against COVID-19  22d Jan 2021

CPO to Healthcare Sector - Falsified Medicines Directive  14th January 2021

Data Capture from the COVID-19 Vaccination Programme  11th January 2021

Timing of Interval Between COVID-19 Vaccine Doses  8th January 2021

Import Declaration for Medicines and Medical Supplies  8th January 2021

Vaccination of Community Pharmacy Staff   7th January 2021 

Prescription Submission Reminder  6th January 2021

Human Medicines Regulations Amendment PGD  6th January 2021

Seasonal Flu Vaccination Programme 2020/21 - Extension to 50-64 Year Olds  6th Jan 2021

Deployment of COVID-19 Vaccine - Oxford/AstraZeneca Governance, Handling and Preparation in General Practice  5th January 2021 

Lithium Carbonate 200mg and 400mg MR tabs - Supply Alert - Updated 5th Jan 2021

New Variant of SARS-COV-2 Virus in South Africa - Action for HSC    Update 4th Jan 2021

Deployment of the AstraZeneca COVID-19 Vaccine in NI  30th December 2020

Community Pharmacy Remuneration 2021/22  30th December 2020

New Variant of SARS-COV-2 Virus in South Africa - Action for HSC  24th Dec 2020

DOH Correspondence regarding Essential Services  23rd December 2020

The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020  21 Dec 2020

Updated Resuscitation Council UK Guidance on The Management of Anaphylaxis in the Vaccination Setting  18th December 2020

Bilxona (Gliclazide MR) Discontinuation Letter and Appendix  17th December 2020

Prescriptions Issued by EEA Health Professionals Following Transition Period  17/12/2020

Businesses and Service Providers Trade Webinar 

COVID-19 Vaccination - Co-administering Vaccines to Care Homes  11th December 2020

Adrenaline for Anaphylaxis Kits - A Reminder to Health Care Professionals  10th December 2020 

Changing Lives Through Community Pain Support Programmes Bulletin  10th Dec 2020

Pfizer Biontech Covid-19 Vaccine - Updated Guidance on Managing Allergic Reactions 10th December 2020

Continuation of Seasonal Flu Programme by Peer Vaccinators  9th December 2020

COVID-19 Vaccination – Co-administering with other vaccines   8th December 2020

Deployment of the COVID-19 Vaccine in Northern Ireland  8th December 2020

Winter Vaccines and Research and attached Letter  7th December 2020

COVID-19 Antibody Testing Study  4th December 2020

National Patient Safety Alert - Emergency Steroid Card  3rd December 2020

Confirmed Influenza Isolates in NI - NICE Guidance on Use of Antivirals Now Applies   3rd December 2020

Managing Requests for Repeat Meds - Christmas and New Year Holidays  03/12/2020

Managing Requests for Repeat Meds - Christmas and New Year -  Appendices 03/12/2020

EU Transition Update - Stakeholder Engagement Sessions  3rd December 2020

EU Transition for Community Pharmacy  3rd December 2020

Prescribing Over the Counter Meds and Items on Stop List  2nd December 2020

Supervision of Opioid Substitution Treatment  25th November 2020

Useful Guide to Mental and Emotional Wellbeing Resources  24th Nov 2020

HSC Regional Staff Wellbeing Framework  24th November 2020

FPS - Supporting Health and Wellbeing Needs of Staff  24th November 2020

Letter to GPs and CPs - Repeat Prescription Guidance Implementation  24th Nov 2020

Prescription Submission Reminder  24th November 2020

(Addendum) - Seasonal Influenza Vaccination Programme  19th November 2020

Discontinue Use of Target and HSCB Antimicrobial PILs  19th November 2020

New Models of Prescribing (NMOP) - Next Steps  19th November 2020

Expression of Interest - Reg Health Care Professionals - Sessional Vaccinators for COVID-19 Vaccination Programme  17th November 2020

Consultation on Proposals to Change Medicines Responsibilities  12th Nov 2020

URGENT Alert to Community Pharmacies - Missing Prescription Pad  11th Nov 2020

Insulin Safety in Primary Care Supplement  10th November 2020

Letter to Trusts - Dispensing on Discharge from Hospital  29th October 2020

Dispensing on Discharge from Hospital (28 day supply policy)  Updated 18th Nov 2020

Levomepromazine 6mg tablets - Licensed Product  29th October 2020

Alert to all CPs - Stolen Dental Prescriptions (HS21D) Handwritten  28th October 2020

Repeat Prescription Management  28th October 2020

HSCB Guidance for Repeat Prescribing Management  28th October 2020

NI Medicines Management Newsletter  October 2020

HSCB Correspondence - Building the CP Partnership Programme  20th Oct 2020

Ending of Serious Shortage Protocol - Fluoxetine 40mg caps  13th October 2020

Healthy Living Centre Pain Support Programmes  7th October 2020

HSC Secure Email Go Live  1st October 2020

Primary Care Email Communication Policy to CP  1st October 2020

Community Pharmacy Services - Additional Funding 20/21  24th September 2020

MPS 2712 - NI Code Book - pdf full version retired  24th September 2020

Letter to All HSCW Encouraging Everyone to Obtain the Flu Vaccination 23rd September 2020

Learning - Controlled Drugs Stock Orders  18th September 2020

Independent Prescribing in Community Pharmacy  17th September 2020

Management of Seasonal Flu 2020 - 2021  17th September 2020

MDS  - CP Review of Patients Receiving MDS   4th Spetember 2020

MDS  - Survey Findings  4th September 2020

MDS  - Risk review  4th September 2020

MDS  - Referral Form  4th September 2020

MDS  - Summary Report and Claim Form  4th September 2020

MPS 2707 - Reminder - Prescription Submissions to BSO  3rd September 2020

Larvae / Biobag - Invoice Submission Now Required  28th August 2020

Recommencement of Minor Ailment Service  28th August 2020 

NATIONAL PATIENT SAFETY ALERT - STEROID EMERGENCY CARD TO SUPPORT EARLY RECOGNITION AND TREATMENT OF ADRENAL CRISIS IN ADULTS  27th August 2020

HEALTHCARE SAFETY INVESTIGATION BRANCH NATIONAL LEARNING REPORT - SEVERE BRAIN INJURY, EARLY NEONATAL DEATH AND INTRAPARTUM STILLBIRTH ASSOCIATED WITH GROUP B STREPTOCOCCUS INFECTION  19/08/2020

Seasonal Influenza Vaccination Programme 2020/21  20th August 2020

CP Flu Vaccination Service (CPFV) - Expression of Interest Letter

CP Flu Vaccination Service (CPFV) - Service Contract

Espranor Supervision Fee - UPDATE  12th August 2020

Shingles Vaccination Programme - Eligibility Criteria 2020/21  6th August 2020

MPS 2691 - Ranitidine 150mg & 300mg tabs - Removal from Drug Tariff  31/07/20

Home Enteral Tube Feeding Survey  31st July 2020

Training for Pharmacy Support Staff - Funding Extension  30th July 2020

Evidence of Harm from Illicit or Fake Benzodiazepines  27th July 2020

Prescribing of VSL#3 and Vivomixx Probiotics  22nd July 2020

Alert - Cannabis Oil Disguised as Confectionary  21st July 2020

Cannabis-Based Medicinal Products - Update  21st July 2020

Community Pharmacy Commissioning Plan 2020/21  3rd July 2020

Letter to Primary Care Practitioners - Learning from Reported Meds Incidents 02.07.20

Learning from Reported Meds Incidents Annual Report 2018

Community Pharmacy Commissioning Plan 2020/21  1st July 2020

New CD Stock Requisition Forms (Schedule 2&3) - 30th June 2020

New CD Stock Requisition Forms - Appendix 2

Misuse of Hyoscine Butylbromide (Buscopan)  17th June 2020

Re-Scheduling of Epidyolex (Cannabis Based Medicine) - Letter from CMO 15.06.20

Cardiopulmonary Resuscitation (CPR) as an Aerosol Generating Procedure  13.06.20

Letter from CPO and CAHPO - HCPC Registered Orthoptists 9th June 2020

MPS 2664 - Serious Shortage Protocol - Submission Information 27th May 2020

Pharmacy Alert - Missing Prescription Pad  20th May 2020

MPS 2659 - Clenil Modulite 100mcg Batch Variation - Key Dispensing Points  06.05.2020

Terbutaline 500mcg/dose Dry Powder Inhaler : Ensure Correct Quantity is Prescribed 05.05.2020

Addition of Omeprazole 10mg/5ml Oral Susp SF and 20mg/5ml Oral Susp SF NEW

Bank Holiday Friday 8th May - Opening Intentions  NEW

HSC Secure Email - Test Email Reminder  NEW

HSCNI Email Service - A Step-by-Step User Guide  NEW

End of 2019 - 2020 Flu Season and Related Issues  NEW

Additions to Palliative Care Stock List  1st April 2020

Stand Down Supervision Arrangements 

HSC Secure Email Letter and Step by Step User Guide 

Arrangements for Managing Prescriptions 

Postponement of Medicines Optimisation Quality Framework Workshop - 25/03/20 

Clinical Staff Encountering Patients with Respiratory Infections Arrived From Overseas 

EU Exit - Retention of Stockpiles - Chief Pharmaceutical Officer 

COVID-19 Becomes a Notifiable Disease 

CP Remuneration 2020-21 and Global Sum Fees 

Updated Advice (Covid-19) Coronavirus - Primary Care - Secondary Care 

Declaration and Self-Assessments 2020 

Update Advice in Relation to the Novel Coronavirus - Flow Chart - SPOC Contacts 

Cannabis Based Products for Medicinal Use - UPDATE 

Updated Advice - Novel Coronavirus (2019-nCoV)  and  Flow Chart

CANCELLATION of Medicines Optimisation Quality Framework Workshop 

Wuhan Novel Coronavirus - Message For All Clinical Staff  and  Flow Chart 

Change to Infant Pneumococcal Conjugate Vaccine (PCV13) Schedule 

MPS 2616 - Invoice Submission - UPDATE 

Medicines Optimisation Quality Framework 

Melatonin Preparations - Prescribing and Supply 

MPS 2608 - Invoice Submissions 

Yellow Fever Vaccine - Extreme Caution and New Recommendations 

Confirmed Influenza Isolates - NICE Guidance on Use of Antivirals 

Supply Route for Insulin Safety Needles 

The Misuse of Drugs (Amendment) Regulations (NI) 2019 

Pertussis (Whooping Cough) Vaccination of Pregnant Women - UPDATE 

Christmas & New Year Holidays - Managing Requests For Repeat Meds 

Installment Dispensing Issues and Proforma 

Review of Topical Steroid Prescribing 

Carbon Monoxide Poisoning - Ongoing Vigilance 

Opicapone 50mg Capsules - Supply Disruption Alert 

Mitomycin Supply Disruption Alert 

Expected Delay - Fluenz Tetra Flu Vaccine 

MPS 2586 - Melatonin 1mg/ml oral solution sugar free

EU Exit Guidance 

New Measures to Help Manage Medicines Shortages 

Pharmacy Needs Assessment - Focus Groups 

MPS 2574 - Mianserin Supply Issue   

Management of Seasonal Fu 2019/20 (a) 

Management of Seasonal Fu 2019/20 (b) 

Update on BEXSERO (Meningitis B) Vaccine Patient Info Leaflet 

MPS 2573 - Provera 100mg tablets Supply Issue

Community Pharmacists Clinic Times 2019 - Seasonal Flu Vaccine 

MPS 2572 - Fluoxetine 10mg, 30mg, 40mg Caps Supply Issue 

MPS 2571 - Capsaicin Cream Supply Issue 

Phenobarbital Elixir Alcohol Level Guidance 

Letter to HSC Providers - EU Exit Update 

EU Exit Operational Guidance Letter from DoH 

EU Exit Operational Readiness Guidance 

Hormone Replacement Therapy (HRT) Further Information 

Support and Delivery of Domiciliary Care Payment 

Hormone Replacement Therapy (HRT) Supply Issues 

Delayed Diagnosis of DKA and Type 1 Diabetes in a young Adult 

MUR Service Evaluation - Patient Referrals to GP Practice 

Seasonal Influenza Vaccination Programme 2019-20 

 

CBD Letter to Pharmacists 

Pre-registration Pharmacist Placements Update 2019-20 

Pre-registration Pharmacist Placements Update 2018-19 

Supply Disruption - Emerade 500mcg and 300mcg Adrenaline Auto Injector Device 

Update on Cannon Hygiene Collections 

Use of Hernia Mesh 

MMS 1892 - Appliances and Drug Tariff 

MPS 2559 - Appliances and Drug Tariff 

Extension of HPV Vaccination to Boys Aged 12-13 Years   and Annex A 

Planned Exit of the UK from the European Union 

Joint Letter from BSO & McLernons - Connectivity to Pharmacy Portal 

Red Amber List Update - June 2019 

Disophyramide 100mg & 150mg Capsules Supply Disruption 

Epanutin Supply Disruption Alert  

Compliance Support / Medicines Adherence Payments 

Shingles Vaccination Programme - Eligibility Criteria 2019/20 

Diamorphine 5mg Injection Supply Issue 

Microgynon 30 and Ovranette tablets Supply Issue 

Yellow Fever Vaccine (Stamaril) Extreme Caution 

Rapid Treatment Required - DNP Poisoning 

Loestrin Tablets Supply Issue 

Community Pharmacy MUR Service 2019/20 

End of 2018-19 Flu Season and Related Issues 

MPS 2553 - Cannon Hygiene 

Wound Care Management Transitional Payment 

Guidelines on Choice of Glucometers and Ketometers for Adults Type 1 

Diabetes Consumables For Children and Young People Type 1 

MPS 2550 - Common Coding Issues 

Missing Prescriptions Alert 

Outcome of Review of Pre-School Childhood vaccination

MPS 2549 - Labetalol Tablets Supply Issue

MPS 2548 - Levomepromazine 25mg/ml injection supply issue

Pharmacy Alert - Stolen Prescriptions 

Critical Medicines Letter and Crucial Timelines 

MPS 2547 - Woundcare Management Products - Reminder 

Fluoroquinolone Antibiotics - New Restrictions and Precautions 

Gabapentin and Pregabalin - Schedule 3 CD from 1st April 2019 

MPS 2544 - Wound Care Products - Changes to NI Drug Tariff April 2019 

Cannabis Based Products for Pain 

Declaration and Self-Assessments Form 

Early Alert System 

Antenatal Rubella Screening

The Misuse of Drugs Act amendments

Medical Device Alert - Accu-Chek Insight insulin pump & Field Safety Notice

Metoprolol 50mg and 100mg Supply Issue

Exit From The EU - Medicines and Medical Supplies 

MPS 2540 - Wound Care Management : Changes to N.I. Drug Tariff 

Advice of Changes to Drug Tariff and Wound Care Products 

Implementation of the FMD (Falsified Medicines Directive) 

Pre-Registration 2019/20 

Medical Device Alert - Freestyle Libre Skin Sensitivity 

MPS 2537 - Pharmacy First Service - Patient Group Direction 

Patient Group Direction Document 

MPS 2534 - Larvae Products 

Misdiagnosis of Diabetic Ketoacidosis in Children 

Clexane 40mg Injection Supply Issue 

Reporting Medical Device and Estates Incidents  

 

..

 

 

.